Good news for physicians. A new scoring method called S 2 TOP-BLEED predicts 3-year major bleeding risk in patients with a transient ischemic attack (TIA) or ischemic stroke who are receiving antiplatelet drugs. Based on 10 readily available characteristics, doctors can estimate the risk of a major bleed on antiplatelet therapy for an individual patient. Antiplatelet drugs such as Aspirin and Clopidogrel are administered after a stroke to prevent further formation of clots, however, these medications also increase the risk of major bleeding that can cause death or disability.
S 2 TOP- BLEED method predicts risk of major bleeding in patients who are receiving antiplatelet drugs after ischemic stroke based on 10 readily available patient characteristics. This will allow physicians for judicious use of antiplatelet drugs in patients with high risk of bleeding after stroke. Methods To…
